showed a trendp < 0.05
Supplementation with HMB also showed a trend towards longer survival time, with subcutaneous TB group doubling survival time to 28 days ( p < 0.05), while the intraperitoneal TB group showed a 42% increase (NS), possibly indicating that HMB needs time to effect a change [ 85 ].